Role of HGF/MET axis in resistance of lung cancer to contemporary management. - Wikidata - awgldk - TriplyDB

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

http://www.wikidata.org/entity/Q35200337

about

A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway.Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report.Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.

P2860

Q36413058-F072A321-F3D3-4622-94AF-A585A20178E2 Q37687364-9D7193CA-293B-4F72-BC40-76547F6FC8B6 Q38706872-5291E393-D49C-4FA9-808E-277FDDFD7D38 Q42152754-71E55B99-7B68-4353-BB95-61FCCA494953 Q42373819-9ED24827-A242-4B06-B257-F4BFE1849760 Q47157413-EB91A62E-C4D7-448B-97D4-48B80733D4D7 Q49887893-1B65C251-88A5-4B8A-9AB9-40580DED5885

P2860

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

http://www.wikidata.org/entity/Q35200337

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

@ast

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

@en

type

label

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

@ast

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

@en

prefLabel

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

@ast

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

@en

P1433

Q35200337-3014091E-54C6-44AA-B9CB-6A37A2DD3C33

P1476

Q35200337-8B0F237F-F596-43FF-80D1-2E6C559659ED

P2093

Q35200337-96B38DC9-81D8-4C5A-87A1-68ABDF00D73E

Q35200337-97B10166-BF1D-416F-9534-0C73006B0230

P2860

Q35200337-00A98A5D-2D4B-47AC-B757-A80C3E5615E5

Q35200337-0136C498-4694-49AB-91E5-BA125A03C434

Q35200337-03BFCABD-A885-4482-BFA6-EA7C7DF378D2

Q35200337-05CE7A13-3CEC-4E56-A576-159582088575

Q35200337-074F942C-8700-4F25-822F-8E4065EC31F1

Q35200337-08E0A1FE-FBA7-4072-BF83-3FAB7C26BB74

Q35200337-0C612204-BB9D-41DF-A067-E871162047F3

Q35200337-0DFB21E7-D5FD-4AC9-B01B-A04351967763

Q35200337-110D93B8-7E4A-410D-BD31-D0F9DE62F6F6

Q35200337-11E2EAFC-CD59-486D-B08D-AB39FD30CC2E

P304

Q35200337-9E1BFA48-8A38-4CFB-A1BA-2389D5921932

P31

Q35200337-7A4FAAD3-69BC-4D57-BB83-6325178660D6

P356

Q35200337-50A19C7E-BD9B-41E1-B1C3-3A536962ABF6

P433

Q35200337-8703DD4A-02CB-403A-AF06-12DC7FF299CD

P478

Q35200337-8AF335DC-5F2A-48CD-BFCD-CDA49987BFC3

P50

Q35200337-5EADA8F1-FE70-4FCB-89DA-6830ADD01A9F

P577

Q35200337-991782C2-A469-4B18-AD2D-E559AE94445D

P698

Q35200337-020CE4EE-29C6-43E5-B2A2-02B3042583D9

P932

Q35200337-486A17DD-F7A9-45A6-8C54-123F780C7EFE

P356

J.ISSN.2218-6751.2012.09.04

P1433

Translational lung cancer research

P1476

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

@en

P2093

Ana Maria Gonzalez-Angulo

http://www.w3.org/2001/XMLSchema#string

Kanwal Pratap Singh Raghav

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular characterization of mitochondrial apoptosis-inducing factor

Global cancer statistics

Concurrent chemoradiotherapy in non-small cell lung cancer

Molecular cloning and expression of human hepatocyte growth factor

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Essential role of Gab1 for signaling by the c-Met receptor in vivo

Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding

Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

P304

179-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2218-6751.2012.09.04

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

George R Blumenschein

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25806180

http://www.w3.org/2001/XMLSchema#string

P932

4367559

http://www.w3.org/2001/XMLSchema#string